Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 21075 | 1-cyanocyclohexyl 4-methylbenzenesulfonate | 90775-01-2 | ≧98.0% |  |
| 1-cyanocyclohexyl 4-methylbenzenesulfonate (CAS 90775-01-2 ) is an important building | ||||
| 20368 | SHMT-IN-2 | 2102681-49-0 | ≧98.0% |  |
| SHMT-IN-2 is a serine hydroxymethyltransferase (SHMT) inhibitor, potently inhibiting | ||||
| 171553 | Anle138b | 882697-00-9 | ≧98.0% |  |
| Anle138b is an oral, brain-penetrant, general inhibitor of protein aggregation. It wa | ||||
| 18435 | Ritlecitinib ( PF-06651600 ) | 1792180-81-4 | ≧98.0% |  |
| Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a | ||||
| 2091204 | 5-hydroxy-2,4-dimethylpyrimidine | 412003-95-3 | ≧96.0% |  |
| 2,4-dimethylpyrimidin-5-ol is a key intermidiate ofLemborexant. Kg scale may be provi | ||||
| 20344 | SMN-C3 | 1449597-34-5 | ≧98.0% |  |
| SMN-C3is an orally active SMN2 splicing modulator and has the potential to treat spin | ||||
| 20369 | Sunvozertinib ( DZD 9008 ) | 2370013-12-8 | ≧98.0% | _2370013-12-8.png) |
| Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective | ||||
| 1711225 | Fosgonimeton (ATH-1017) | 2093305-05-4 | ≧98.0% |  |
| Fosgonimeton (ATH-1017) is a small molecule which enhance the activity of hepatocyte | ||||
| 122622 | CNS004 | 695205-24-4 | ≧98.0% |  |
| CNS004 is a novel compound that potentiates NMDA receptor currents based on glutamate | ||||
| 20103004 | 2,6-difluoro-3,5-dimethoxybenzeneamine | 651734-54-2 | ≧98.0% |  |
| 2,6-difluoro-3,5-dimethoxybenzeneamine is a key intermeidate ofPemigatinib.1Kg~10Kg s | ||||
| 61726 | Ensifentrine ( RPL554 ) | 1884461-72-6 | ≧98.0% | _1884461-72-6.png) |
| Ensifentrine (RPL554) is an investigational, first-in-class, inhaled dual inhibitor o | ||||
| 822221 | IACS-13909 | 2160546-07-4 | ≧98.0% |  |
| IACS-13909 is a specific and potent allosteric inhibitor of SHP2, that suppresses sig | ||||